PhD Studentship: The role of the gut microbiota in breast cancer (HALLQ18BC)

🔒 Confidential Employer
Posted 3 May 2026
LOCATION
Norwich
TYPE
Full-time
LEVEL
Entry-level
SALARY
£14,553 / year
CATEGORY
Science & Research
This employer holds a UK Home Office sponsor license — sponsorship for this specific role is at the employer’s discretion

SKILLS

Microbiota sampling and processing Bioinformatics Microbiological techniques Cell culture Immune assays Clinical cohort management In vitro modelling Data analysis

FULL DESCRIPTION

PhD Studentship: The role of the gut microbiota in breast cancer (HALLQ18BC)

Company: [Employer hidden — view at passion-project.co.uk]

Location: Norwich, UK

Salary: £14,553.00 stipend per year

Contract Length: 4 years

Job Description

We are looking for a creative and motivated PhD candidate to join a dynamic, multi-disciplinary research team investigating microbiota and host interactions. This position is within Dr Lindsay Hall’s lab (www.halllab.co.uk) at the [Employer hidden] (https://quadram.ac.uk/) which will move (mid-2018) into a new interdisciplinary research building at the forefront of a new era in gut microbes, food, and health research, and with Dr Stephen Robinson (Biological Sciences, University of East Anglia, http://therobinsonlab.co.uk/).

Background: Breast Cancer (BC) is a leading cause of cancer-related death among females worldwide. Most patients present with localised tumours, associated with high five-year survival rates, however ~20-40% will relapse systemically and survival plunges (<25%) for patients with metastases. Unlike other metastatic cancers, it’s incurable and prolonging patients’ lives by a mere few years is expensive. The cascade of steps leading to BC development depends on reciprocal interactions between cancer cells and their local environment including the immune system. A key link to these immune components is our resident microbiota, which modulates mucosal and systemic immune responses. Thus, the gut-tumour axis may be critical in pro- and anti-cancer responses at primary tumour and metastatic stages. Probing microbiota and immune responses in BC patients, will determine factors driving progression during early disease stages and help devise counteracting approaches, improving outcomes and treatment responses.

The goal of this Big C PhD studentship is to understand how microbiota profiles in BC patients compares to healthy volunteers, how these differences relate to immune responses and clinical readouts, and determine impact of specific microbes on immune responses using in vitro models. This is a multidisciplinary project and a variety of techniques will be utilised throughout the PhD including clinical cohort management, microbiota sampling and processing, bioinformatics, microbiological and cell culture, and immune assays.

Funding Notes

This project is awarded with a 4-year Norfolk Cancer Charity BIG C PhD studentship. Tuition fees are covered for UK/EU rate only (£4195.00 2017/8 rate). Students liable for international tuition fees will need to fund the difference between the UK/EU fee level and the international fee level (£18,000. 2017/8 rate). A stipend will be provided for each year of the studentship (2017/8 rate is £14,553.00). Research training support funding is available.

How to Apply

For further information and to apply, please visit our website: https://students.quadram.ac.uk/how-to-apply/

Sign up free — access 45,000+ UK sponsor-licensed jobs